Genpact Limited (NYSE:G) Forecasted to Post Q3 2025 Earnings of $0.73 Per Share

Genpact Limited (NYSE:G - Free Report) - Research analysts at Zacks Research cut their Q3 2025 EPS estimates for Genpact in a note issued to investors on Monday, April 8th. Zacks Research analyst S. Dey now forecasts that the business services provider will post earnings per share of $0.73 for the quarter, down from their previous forecast of $0.77. The consensus estimate for Genpact's current full-year earnings is $2.70 per share. Zacks Research also issued estimates for Genpact's Q4 2025 earnings at $0.75 EPS, FY2025 earnings at $2.85 EPS and Q1 2026 earnings at $0.72 EPS.

Genpact (NYSE:G - Get Free Report) last released its earnings results on Thursday, February 8th. The business services provider reported $0.68 EPS for the quarter, topping analysts' consensus estimates of $0.65 by $0.03. The business had revenue of $1.15 billion during the quarter, compared to analysts' expectations of $1.12 billion. Genpact had a net margin of 14.10% and a return on equity of 23.19%.

G has been the subject of a number of other research reports. Citigroup boosted their target price on shares of Genpact from $35.00 to $36.00 and gave the stock a "neutral" rating in a research note on Wednesday, January 17th. Needham & Company LLC reissued a "buy" rating and set a $40.00 target price on shares of Genpact in a research note on Friday, February 9th. Mizuho began coverage on shares of Genpact in a research note on Tuesday, January 30th. They set a "neutral" rating and a $40.00 target price for the company. StockNews.com lowered shares of Genpact from a "strong-buy" rating to a "buy" rating in a research report on Friday. Finally, JPMorgan Chase & Co. boosted their price target on shares of Genpact from $42.00 to $43.00 and gave the stock an "underweight" rating in a research report on Friday, February 9th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $40.11.


Check Out Our Latest Report on Genpact

Genpact Price Performance

Shares of G stock traded up $0.54 on Tuesday, reaching $32.36. 1,441,674 shares of the company were exchanged, compared to its average volume of 1,534,767. The company has a market cap of $5.84 billion, a price-to-earnings ratio of 9.43, a P/E/G ratio of 1.49 and a beta of 1.07. The business has a 50-day moving average price of $34.20 and a 200 day moving average price of $34.55. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.44 and a current ratio of 1.44. Genpact has a 1 year low of $29.41 and a 1 year high of $45.99.

Genpact Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Monday, March 11th were issued a $0.153 dividend. This represents a $0.61 annualized dividend and a yield of 1.89%. This is a positive change from Genpact's previous quarterly dividend of $0.14. The ex-dividend date of this dividend was Friday, March 8th. Genpact's payout ratio is presently 17.78%.

Insider Buying and Selling at Genpact

In other Genpact news, SVP Heather White sold 11,450 shares of the business's stock in a transaction dated Monday, January 22nd. The shares were sold at an average price of $36.00, for a total value of $412,200.00. Following the transaction, the senior vice president now directly owns 21,175 shares in the company, valued at approximately $762,300. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.80% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of G. Neuberger Berman Group LLC lifted its stake in shares of Genpact by 2.2% in the 1st quarter. Neuberger Berman Group LLC now owns 12,165 shares of the business services provider's stock worth $529,000 after acquiring an additional 258 shares during the period. Pathstone Family Office LLC increased its holdings in Genpact by 1.8% during the 4th quarter. Pathstone Family Office LLC now owns 15,076 shares of the business services provider's stock valued at $697,000 after acquiring an additional 265 shares in the last quarter. American Trust increased its holdings in Genpact by 2.8% during the 4th quarter. American Trust now owns 10,888 shares of the business services provider's stock valued at $504,000 after acquiring an additional 298 shares in the last quarter. Belpointe Asset Management LLC increased its holdings in Genpact by 27.6% during the 1st quarter. Belpointe Asset Management LLC now owns 1,446 shares of the business services provider's stock valued at $67,000 after acquiring an additional 313 shares in the last quarter. Finally, Cresset Asset Management LLC boosted its stake in shares of Genpact by 6.1% during the 1st quarter. Cresset Asset Management LLC now owns 5,645 shares of the business services provider's stock worth $246,000 after purchasing an additional 326 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.

Genpact Company Profile

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Earnings History and Estimates for Genpact (NYSE:G)

Should you invest $1,000 in Genpact right now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Featured Articles and Offers

7 Must-Buy Stocks Under $20

7 Must-Buy Stocks Under $20

In this video, we highlight seven stocks under $20 that are worth a closer look.

Search Headlines: